Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Immune Environment in Glioblastoma (Feb 2023)
    • Korsmeyer Award 25th Anniversary Collection (Jan 2023)
    • Aging (Jul 2022)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Research letters
    • Letters to the editor
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Research letters
  • Letters to the editor
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI117244

Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation.

R Roubenoff, R A Roubenoff, J G Cannon, J J Kehayias, H Zhuang, B Dawson-Hughes, C A Dinarello, and I H Rosenberg

United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.

Find articles by Roubenoff, R. in: JCI | PubMed | Google Scholar

United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.

Find articles by Roubenoff, R. in: JCI | PubMed | Google Scholar

United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.

Find articles by Cannon, J. in: JCI | PubMed | Google Scholar

United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.

Find articles by Kehayias, J. in: JCI | PubMed | Google Scholar

United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.

Find articles by Zhuang, H. in: JCI | PubMed | Google Scholar

United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.

Find articles by Dawson-Hughes, B. in: JCI | PubMed | Google Scholar

United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.

Find articles by Dinarello, C. in: JCI | PubMed | Google Scholar

United States Department of Agriculture Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.

Find articles by Rosenberg, I. in: JCI | PubMed | Google Scholar

Published June 1, 1994 - More info

Published in Volume 93, Issue 6 on June 1, 1994
J Clin Invest. 1994;93(6):2379–2386. https://doi.org/10.1172/JCI117244.
© 1994 The American Society for Clinical Investigation
Published June 1, 1994 - Version history
View PDF
Abstract

The cytokines IL-1 beta and TNF-alpha cause cachexia and hypermetabolism in animal models, but their role in human inflammation remains controversial. The relationship between in vitro cytokine production and metabolism was examined in 23 adults with RA and 23 healthy control subjects matched on age, sex, race, and weight. Body composition was measured by multicompartmental analysis of body cell mass, water, fat, and bone mass. Resting energy expenditure (REE) was measured by indirect calorimetry. Cytokine production by PBMC was measured by radioimmunoassay. Usual energy intake, physical activity, disability scores, medication use, and other confounders were also measured. Body cell mass was 13% lower (P < 0.00001), REE was 12% higher (P < 0.008), and physical activity was much lower (P < 0.001) in subjects with RA. Production of TNF-alpha was higher in RA than controls, both before and after stimulation with endotoxin (P < 0.05), while production of IL-1 beta was higher with endotoxin stimulation (P < 0.01). In multivariate analysis, cytokine production was directly associated with REE (P < 0.001) in patients but not in controls. While energy and protein intake were similar in the two groups and exceeded the Recommended Dietary Allowances, energy intake in subjects with RA was inversely associated with IL-1 beta production (P < 0.005). In this study we conclude that: loss of body cell mass is common in RA; cytokine production in RA is associated with altered energy metabolism and intake, despite a theoretically adequate diet; and TNF-alpha and IL-1 beta modulate energy metabolism and body composition in RA.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2379
page 2379
icon of scanned page 2380
page 2380
icon of scanned page 2381
page 2381
icon of scanned page 2382
page 2382
icon of scanned page 2383
page 2383
icon of scanned page 2384
page 2384
icon of scanned page 2385
page 2385
icon of scanned page 2386
page 2386
Version history
  • Version 1 (June 1, 1994): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2023 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts